Trials / Completed
CompletedNCT00991341
Red Cell Storage Duration Study
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1,481 (actual)
- Sponsor
- Carelon Research · Academic / Other
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The RECESS study will compare the effects of transfusing red blood cell units stored \<= 10 days vs. red blood cell units stored \>= 21 days, in patients who are undergoing complex cardiac surgery and are likely to need a red blood cell transfusion. The primary hypothesis is that there is a clinically important difference between the effects of shorter-storage red cell units and longer-storage red cell units on clinical outcomes and mortality risk.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Red blood cell units stored <= 10 days | Pre-storage leukoreduced red blood cell units stored \<=10 days at time of transfusion. Can be AS1, AS3, or AS5. Frozen, deglycerolized, washed, and volume-reduced products are protocol violations. |
| BIOLOGICAL | Red blood cell units stored >= 21 days | Pre-storage leukoreduced red blood cell units stored \>=21 days at time of transfusion. Can be AS1, AS3, or AS5. Frozen, deglycerolized, washed, and volume-reduced products are protocol violations. |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2014-03-01
- Completion
- 2014-03-01
- First posted
- 2009-10-08
- Last updated
- 2015-06-09
- Results posted
- 2015-06-09
Locations
33 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00991341. Inclusion in this directory is not an endorsement.